Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies

Clinical trial NCT01947140 · COMPLETED

Trial details

NCT number: NCT01947140
Sponsor: Jennifer Amengual
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoid Malignancies Multiple Myeloma Lymphoma Hodgkin Lymphoma Non-hodgkin Lymphoma

Start date: 2013-09-09
Primary completion: 2022-09-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.